Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Unraveling the T–B tangle in anti-CD20 multiple sclerosis therapy | PNAS
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
CD-20 | ドライブレコーダー | セルスター工業株式会社
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better? | SpringerLink
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Espressione di CD20 sui linfociti B nel midollo osseo ed in periferia.... | Download Scientific Diagram
Cells | Free Full-Text | Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients | HTML
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus - ScienceDirect
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives - Kidney International
Expression of CD19 and CD20 according to maturation steps. CD19 is... | Download Scientific Diagram